New test aims to predict who wins the fight against bladder cancer
NCT ID NCT06738797
Summary
This study is testing a new laboratory method called SPHERTEST to see if it can predict whether a patient's advanced bladder cancer will respond to immunotherapy drugs. Researchers will grow tiny 3D tumor models using cells from 32 patients and see how they react to immunotherapy in a dish. The goal is to match the test results with how well the patients actually do on their real-world treatment, hoping to find a better way to choose the right therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROGENITAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nimes
RECRUITINGNîmes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Antoine Lacassagne
NOT_YET_RECRUITINGNice, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Régional du Cancer de Montpellier
NOT_YET_RECRUITINGMontpellier, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut du Cancer de Montpellier
NOT_YET_RECRUITINGMontpellier, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Iuct Oncopole
RECRUITINGToulouse, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.